Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
NC elections upended by Helene: Voting could be delayed, ballots might be lost. Here's what you need to know
Recommended
Ask the meteorologist: Why was Helene so devastating for NC mountains?
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Immunitybio Inc
(NQ:
IBRX
)
3.600
-0.120 (-3.23%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Immunitybio Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
September 12, 2024
Via
Benzinga
Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday
September 09, 2024
Via
Benzinga
ImmunityBio Presents Positive Long-Term Overall Survival Data in Non-Small Cell Lung Cancer Patients and Announces Registrational Intent Phase 3 Trials with ANKTIVA® and Checkpoint Immunotherapy at World Conference on Lung Cancer
September 09, 2024
From
ImmunityBio, Inc.
Via
Business Wire
How Is The Market Feeling About ImmunityBio?
May 17, 2024
Via
Benzinga
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 19, 2024
Via
Benzinga
Top 3 Health Care Stocks That Are Set To Fly This Quarter
August 16, 2024
Via
Benzinga
9 Health Care Stocks Whale Activity In Today's Session
August 13, 2024
Via
Benzinga
IBRX Stock Earnings: ImmunityBio Misses EPS, Misses Revenue for Q2 2024
August 12, 2024
IBRX stock results show that ImmunityBio missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Via
InvestorPlace
ImmunityBio’s ANKTIVA® Now Covered By More Than a Dozen Insurance Plans Representing Over 100 Million Lives Within Months of FDA Approval
August 12, 2024
From
ImmunityBio, Inc.
Via
Business Wire
ImmunityBio Announces Study of ANKTIVA® in Combination with the AdHER2DC Cancer Vaccine as a Potential Therapy to Control Endometrial Cancer
August 06, 2024
From
ImmunityBio, Inc.
Via
Business Wire
IMMUNITYBIO INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of ImmunityBio, Inc. - IBRX
July 26, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
7 Biotech Stocks to Keep on Your Clinical Radar
July 23, 2024
Biotech stocks have always been relevant. However, with the latest shift in the political race, this sector is bound to grab more eyeballs.
Via
InvestorPlace
3 Top Cancer Treatment Stocks to Buy Now
July 17, 2024
These cancer treatment stocks are well-positioned to benefit tremendously from strong demand for their cancer treatments in the longer term.
Via
InvestorPlace
China's Bilibili And Ollie's Bargain Outlet Were Among 10 Mid Cap Stocks With Biggest Gains In The Last Week (June 16-June 22, 2024): Are They In Your Portfolio?
June 23, 2024
Top performing mid-cap stocks last week: BILI (+23%), IBRX (+22%), SSL (+20%), OLLI (+15%), ITCI (+13%), AMKR (+12%), IRTC (+11%), RKLB (+11%), BFH (+10%), BRFS (+10%).
Via
Benzinga
Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
June 20, 2024
Via
Benzinga
Why ImmunityBio Stock Is Trading Higher Thursday
June 20, 2024
The company announced insurance coverage of ANKTIVA, a immunotherapy used to treat non-muscle invasive bladder cancer that was unresponsive to other specific treatments.
Via
Benzinga
KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday
June 20, 2024
Via
Benzinga
ImmunityBio Announces Insurance Coverage of ANKTIVA® Across Multiple States with First Commercial Doses Administered Just Weeks After FDA Approval—Opening New Era for Immunotherapy Beyond Checkpoint Inhibitors
June 20, 2024
From
ImmunityBio, Inc.
Via
Business Wire
3 Short-Squeeze Stocks Outwitting the Pessimistic Predictions
June 20, 2024
Don't be discouraged by the bears. Here are my three picks of short-squeeze stocks to buy for investors everywhere.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
June 11, 2024
Via
Benzinga
ImmunityBio Announces 2024 Annual Meeting of Stockholders with Company Update
June 07, 2024
From
ImmunityBio, Inc.
Via
Business Wire
These 3 Interesting Stocks Are Seeing Heavy Short Interest In June 2024
June 04, 2024
Economic slowdown meets short-selling speculations. Candidates for incoming market volatility are here.
Via
Talk Markets
Connecting the Dots of ANKTIVA’s Triangle Offense: A Deep Dive with Dr. Patrick Soon-Shiong and Dr. Ashish Kamat in a Three-Part UroToday Podcast
May 17, 2024
From
ImmunityBio, Inc.
Via
Business Wire
Amid Biotech Pitfalls, ImmunityBio Has Outperformed NVDA In The Last 3 Months
May 13, 2024
In the last three months, IBRX outperformed NVDA by over 3x.
Via
Talk Markets
IBRX Stock Earnings: ImmunityBio Misses EPS, Beats Revenue for Q1 2024
May 10, 2024
IBRX stock results show that ImmunityBio missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via
InvestorPlace
The 3 Best Bargain Stocks to Buy in May 2024
May 09, 2024
There are several types of bargain stocks for investors to consider. Here are the three best bargain stocks to buy now.
Via
InvestorPlace
Tempur Sealy Posts Upbeat Earnings, Joins FibroGen, Coca-Cola Consolidated, Fabrinet And Other Big Stocks Moving Higher On Tuesday
May 07, 2024
Via
Benzinga
ImmunityBio Completes GMP Drug Substance Manufacturing Sufficient for 170,000 Doses of ANKTIVA®
May 07, 2024
From
ImmunityBio, Inc.
Via
Business Wire
Even Worse than Gamestop? 3 Meme Stocks That Are Screaming Sells
May 06, 2024
Here are just a few of the top meme stocks to sell immediately. In fact, I wouldn't waste investment dollars on any.
Via
InvestorPlace
Serum Institute of India Inks Large-Scale Supply Deal For BCG Use In ImmunityBio's Bladder Cancer Combo Therapy
May 03, 2024
Unlocking global access to Bacillus Calmette-Guerin (BCG) for cancer therapy. ImmunityBio partners with Serum Institute to expand BCG supply. FDA-approved Anktiva plus BCG for bladder cancer.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.